CHF-6366 Chemical Structure inhaled mAChRs and ADRB2 agonist - Chiesi Farmaceutici S.p.A, Parma, IT

inhaled mAChRs and ADRB2 agonist

Ph. I/II candidate in Asthma and COPD discontinued

soft drug design from previously disclosed lead MABA

J. Med. Chem.

Chiesi Farmaceutici S.p.A, Parma, IT

Context. CHF-6366 (Chiesi Farmaceutici S.p.A) is a muscarinic antagonist and β2 agonist (MABA) being developed as an inhaled treatment for respiratory diseases. Muscarinic antagonists and β2 agonists both act…


 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.